<p>Is chemonucleolysis for painful lower back disc herniation returning? In the 1980s chymopapain achieved fairly wide spread use as a chemonucleolysis agent. Outcomes were highly technique and patient selection dependent. It eventually left the market. Now two large firms have inked a deal to bring a new chemonucleolysis approach to market. Will this one work?</p>

Is chemonucleolysis for painful lower back disc herniation returning? In the 1980s chymopapain achieved fairly wide spread use as a chemonucleolysis agent. Outcomes were highly technique and patient selection dependent. It eventually left the market. Now two large firms have inked a deal to bring a new chemonucleolysis approach to market. Will this one work?

Will a $95 Million Deal Bring Chemonucleolysis Back?

We are the publishers of Orthopedics This Week, the most widely read publication in the Orthopedics industry. Orthopedics is, in our way of thinking, a small town with roughly 250,000 residents. These residents include clinicians, nurses, administrators, staff, suppliers, manufacturers, scientists, sales people, regulators, investors and consultants. So we think of ourselves as the community paper. We hope that our little paper, which we publish 40 times a year, will illuminate, elevate and educate you. Like small town publishers and writers everywhere, we are also part of this community and, for good or ill, that fact finds its way into our attitudes and commentaries. Yes, we are biased—in favor of you, our community. Roughly 3.3 times each month, Orthopedics This Week brings you the latest breaking orthopedic news. We also host innovative technology conferences and publish quarterly Market Forecasts and Analysis. Occasionally we also publish data and conference books. We are part of a unique, essential and endlessly fascinating industry. What a great place to be!

Share Will a $95 Million Deal Bring Chemonucleolysis Back?

Sign up to save your podcasts

Will a $95 Million Deal Bring Chemonucleolysis Back?

Will a $95 Million Deal Bring Chemonucleolysis Back?